Skip to main content

COVID 19 Updates from RheumNow

RheumNow Podcast – BandAids for Rheumatologists (5.14.2021)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com - a website for rheumatologists, by rheumatologists.

We love Rheumatology!

RheumNow Live 2021 Now Available for All

RheumNow Live (RNL) for 2021 was held March 20 - 21 in Fort Worth, TX, and now all can partake in the meeting - by video, podcast or by signing up for Tuesday Nite Rheumatology (TNR).

NSAID Safety with COVID-19 Infection

NSAIDs do not affect COVID outcomes; here we are nearly 16 months into the pandemic, and this is the common sense conclusion of a recent trial published in Lancet Rheumatology.

RheumNow Podcast – Uppers and Downers

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

ACR Updates COVID-19 Vaccine Guidance- April 2021

ACR COVID-19 Vaccine Clinical Guidance Task Force

The ACR COVID-19 Vaccine Clinical Guidance was originally published on February 8, 2021 and updated on March 4, 2021. On April 28, 2021, new recommendations regarding mycophenolate, methotrexate, acetaminophen, and NSAID timing considerations were added.  

Purpose

New Side Effect From mRNA COVID Vaccines?

MedPage Today

Herpes zoster reactivation -- a.k.a. shingles -- following COVID-19 vaccination in six patients with comorbid autoimmune/inflammatory diseases may be a new adverse event associated with the Pfizer/BioNTech mRNA vaccine, suggested a new report.

RheumNow Podcast – Combination Biologics

Dr. Jack Cush serves up this week's news and articles from RheumNow.com.

Planes, Trains and COVID Distancing

MMWR reports the risk of acquiring an infection with SARS-CoV-2 is reduced 23% to 57% when the middle seat was vacant (compared with full aircraft occupancy).

Autoimmune Risk of Death Up during COVID

A population-based study in the UK shows that patients with rare autoimmune rheumatic diseases (RAIRD) were 44% more likely to die during the 2020 COVID-19 pandemic (March - April) compared to either the general population or their pre-COVID risk.

DMARD Dropouts During COVID-19

A full year from the onset of the SARS-COV-2 pandemic, rheumatologists are still seeing the consequences of COVID, with many patients avoiding usual care, follow-up visits, routine lab testing and with many self-stopping their antirheumatic meds, because it seemed like the right thing to do.

RheumNow Podcast – Mistakes with Steroids

Dr Jack Cush gives his spin on this week's RheumNews and Rheum Research from RheumNow.com.

Social

What’s the biggest reason for vaccine hesitancy in your patients? @RheumNow #EULAR2021

Eric Dein @ejdein1 ( View Tweet )

2 weeks 5 days ago
#EULAR LB0003 Pfizer #COVID vax immunogenicity and safety in 686 rheum pts in Israel ⭐️Sero+ for COVID Ab 86% in RMD vs 100% controls ⭐️RTX lowest seropos of 39%, related to time of infusion ⭐️⬇️ with GC, ABA, MMF ⭐️ MTX not seen to significantly ⬇️ @RheumNow @rheum_covid

Eric Dein @ejdein1 ( View Tweet )

2 weeks 5 days ago
Even when we go outright looking for COVID vaccine-related problems in rheum disease patients, we really don't find much. Get your rheumatology patients vaccinated! reassuring from @eular_org COVAX registry, thanks to all involved! @pedrommcmachado LB0002 #EULAR2021 @RheumNow https://t.co/mIBeglQ5KS
David Liew @drdavidliew ( View Tweet )
2 weeks 6 days ago
COVID-19 Global Rheum Alliance Registry: prediction of ARDS by machine learning algorithm in a model using 42 variables including: demographics, rheumatic D, meds and comorb with Sens 0.81, Spe 0.49, AUC 075. Interesting model for close monitoring #OP0288 @Rheumnow #EULAR2021 https://t.co/9YY0jzDx59
Aurelie Najm @AurelieRheumo ( View Tweet )
2 weeks 6 days ago
Presenting now at #EULAR2021 #COVID19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with #rituximab: a cohort study https://t.co/QTGkiMcC2d https://t.co/DJB6GooPuJ
The Lancet Rheumatology @TheLancetRheum ( View Tweet )
2 weeks 6 days ago
wonder if vit D is a surrogate for poor health, low SES, diet? In #SARSCoV2 infection low vit D has worse outcomes but clusters racially (⬇️ by skin tone) & seems related to SES. But perhaps adding vit D can help immune system & be anti-inflammatory #EULAR2021 @RheumNow POS0100 https://t.co/TEf52bLs0i
2 weeks 6 days ago
Zara Izadi presents @rheum_covid data on machine learning algorithms to predict ARDS in RMD patients with COVID. Gradient boosting machine had 81% sensitivity to predict ARDS from baseline data @RheumNow #EULAR2021 Abstr#OP0288 https://t.co/tHlPzeX9He
Richard Conway @RichardPAConway ( View Tweet )
3 weeks ago
Poorer outcomes with #JAKi in pts who get #SARSCoV2 but ? related to line of therapy - worse off if 2nd line advanced Rx in RA vs 1st line? JAKi has short half life so it washes out? And..#baricitinib added to #remdesivir improves outcomes NEJM @RheumNow #EULAR2021 #OP0006 Dunno! https://t.co/583z6Mlw3y
3 weeks ago
Presentation 3480 at #EULAR2021. Your patient is on CellCept, has negative COVID spike IgG and IgM antibodies after vaccination with mRNA vaccination x2. What do you counsel on this test? @RheumNow

Eric Dein @ejdein1 ( View Tweet )

3 weeks ago
#Digital #rheumatology in the era of #COVID-19: evidently increasing inclination of patients and physicians to use digital health apps for recording data- as informed by a national survey by @JK77775 and colleagues #EULAR2021 @ARD_BMJ https://t.co/Uo60qZurhG
3 weeks 1 day ago
×